date/time interval
- July 1, 2008 - June 30, 2011
Optimizing targeted cancer immunotherapy by segregating antitumor function from autoimmune pathogenesis
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
sponsor award ID
- 10207_1